Edgewise Therapeutics, Inc. (EWTX) Tops Q1 EPS by 3c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Freedom Broker Upgrades Element Solutions (ESI) to Buy, 'We would buy ESI aggressively on this news'
• Docusign Inc. (DOCU) PT Raised to $58 at BofA Securities
• The Gap, Inc. (GAP) Tops Q2 EPS by 3c